Owing to its potential benefits in treating diabetes and off-label use for obese conditions, the molecule will bring cumulative sales of more than USD 100 billion by 2029
"Without concerted action, these medicines could contribute to widening the gap between the rich and poor, both between and within countries."
Because GLP-1 medications reduce appetite significantly, some users may not be consuming enough of these key nutrients to support healthy hair growth while taking them
Mild thyroid overmedication can actually accelerate weight loss, which sounds beneficial but carries cardiovascular risks that outweigh any weight loss advantage
Compounded semaglutide typically has a Beyond-Use Date (BUD) ranging from 30 to 90 days, depending on the specific pharmacys formulation and testing
Back Lund PK, Goodman RH, Dee PC, Habener JF (1982) 'Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem', Proceedings of the National Academy of Sciences , 79, 345-49